Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Christie Lundwall, PhD
Eisai Inc, Nutley, New Jersey, Former Employee of Eisai, Inc
PCC
Original Research
Impact of Lemborexant on Daytime Functioning
January 16, 2025
Improved insomnia symptoms with lemborexant treatment may translate into improved daytime functioning.
Craig Chepke
,
Kimberly A. Cote
,
Kate Pinner
, et al
JCP
Original Research
Lemborexant and Daridorexant in Insomnia: NNT, NNH, and LHH
October 2, 2023
This study examined whether differences existed between lemborexant and daridorexant in number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed (LHH)...
Leslie Citrome
,
Timothy R. Juday
,
Christie Lundwall